Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1954 Apr 1;99(4):387-404.
doi: 10.1084/jem.99.4.387.

Selective necrosis of cardiac and skeletal muscle induced experimentally by means of proteolytic enzyme solutions given intravenously

Selective necrosis of cardiac and skeletal muscle induced experimentally by means of proteolytic enzyme solutions given intravenously

A KELLNER et al. J Exp Med. .

Abstract

Focal necrosis of cardiac and skeletal muscle was produced regularly in rabbits by means of a single intravenous or intra-arterial injection of a solution of crude papain. Similar lesions were produced in rats and mice injected with this material. The intravenous injection of solutions of ficin, trypsin, and streptokinase also resulted in comparable lesions of cardiac and skeletal muscle in rabbits. The lesions in the myocardium became apparent within 6 hours after injection of the enzyme; they consisted essentially of focal degeneration and necrosis of the sarcoplasm and myofibrils within a segment of muscle fiber. An inflammatory reaction consisting of a small number of polymorphonuclear leukocytes and considerable numbers of mononuclear cells, and often multi-nucleated giant cells, was present within the lesions. In some instances severely damaged fibers were replaced by fibrous tissue and in others proliferation of muscle cell nuclei and restitution of the fiber appeared to take place. Similar changes of a lesser degree were also observed in skeletal muscle. The findings are discussed in connection with the pathogenesis of the anatomical lesions of rheumatic fever, periarteritis nodosa, and other hypersensitivity states.

PubMed Disclaimer

References

    1. J Exp Med. 1947 May 31;85(6):571-90 - PubMed
    1. J Exp Med. 1924 Sep 30;40(4):543-51 - PubMed
    1. J Exp Med. 1931 Jul 31;54(2):145-65 - PubMed
    1. Science. 1937 Oct 22;86(2234):379 - PubMed
    1. J Exp Med. 1949 Jun 1;89(6):687-98 - PubMed

Substances